EichorEICHOR
Condition: Covid 19 Vaccines Synced from ClinicalTrials.gov · August 07, 2026

Recruiting studies: Covid 19 Vaccines

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Safety and Immunogenicity of a Sub-unit Protein CD40.RBDv Bivalent COVID-19 Vaccine, Adjuvanted or Not, as a Booster in
Phase 1/Phase 2 · 2 location(s) · ANRS, Emerging Infectious Diseases · NCT06255626Safety and Serum Virus Neutralizing Antibody Responses of VYD2311, a COVID-19 Vaccine, and Coadministered VYD2311 With a
Phase 3 · 1 location(s) · Invivyd, Inc. · NCT07655180Thymalfasin (Thymosin Alpha 1; Ta1) as an Enhancer of Vaccine Response Among Older Adults Receiving Booster Doses of COV
Phase 1 · 1 location(s) · The Methodist Hospital Research Institute · NCT06821100Genomics and COVID-19 Vaccine Adverse Events
Phase N/A · 1 location(s) · University of British Columbia · NCT05212792An Experimental Medicine Multicenter Trial to Evaluate the Safety and Immunogenicity of Experimental Versus Authorized S
EARLY_Phase 1 · 3 location(s) · ANRS, Emerging Infectious Diseases · NCT07605520COVID-19 Vaccine Effectiveness Against Recurrent Infection Among Lung Cancer Patients and Biomarker Research
NA · 1 location(s) · Peking Union Medical College Hospital · NCT06168032Testimonials and Navigation in Rheumatology
NA · 3 location(s) · University of Alabama at Birmingham · NCT06469788Researchers At UC San Diego Are Learning About the Benefits of Human Milk and How It Influences Infant and Child Health
Phase N/A · 1 location(s) · University of California, San Diego · NCT05553743COVID-19 Vaccine-induced Inflammatory Heart Disease Prevalence Registry
Phase N/A · 1 location(s) · Ottawa Heart Institute Research Corporation · NCT05046002Dissecting Human Immune Responses to Infection With Influenza or SARS-CoV-2
Phase N/A · 1 location(s) · Washington University School of Medicine · NCT06848309A Study to Learn About a COVID-19 Vaccine in Healthy Adults 18 Through 64 Years of Age
Phase 4 · 5 location(s) · BioNTech SE · NCT07730450COVID-19 Vaccines Safety Tracking (CoVaST)
Phase N/A · 14 location(s) · Masaryk University · NCT04834869Connecting Friends and Health Workers to Boost COVID-19 Vaccination in Latino Communities
NA · 1 location(s) · Johns Hopkins University · NCT06128928Immunogenicity of COVID-19 Vaccines in Tuberculosis Patients
Phase N/A · 1 location(s) · University of Oxford · NCT05571735Study Comparing Safety and Immunogenicity of Intranasal COVID-19 Vaccine and mRNA Booster in Healthy Adults
Phase 1/Phase 2 · 5 location(s) · ANRS, Emerging Infectious Diseases · NCT06821126A Trial of a Next Generation COVID-19 Vaccine Delivered by Inhaled Aerosol
Phase 2 · 2 location(s) · McMaster University · NCT06381739A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Vaccine Formulations
Phase 4 · 6 location(s) · ModernaTX, Inc. · NCT06585241COVID-19 Booster and IIV Schedule in Immunocompromised Hosts
Phase 2 · 3 location(s) · McGill University Health Centre/Research Institute of the Mc · NCT06599658Covid-19 and Influenza Oral Vaccine Study
Phase 1 · 1 location(s) · Vaxine Pty Ltd · NCT06355232
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.